Annual Total Liabilities
$49.78 M
+$17.72 M+55.26%
December 31, 2024
Summary
- As of March 9, 2025, FDMT annual total liabilities is $49.78 million, with the most recent change of +$17.72 million (+55.26%) on December 31, 2024.
- During the last 3 years, FDMT annual total liabilities has risen by +$15.40 million (+44.79%).
- FDMT annual total liabilities is now -62.06% below its all-time high of $131.20 million, reached on December 31, 2019.
Performance
FDMT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$49.78 M
-$1.30 M-2.55%
December 1, 2024
Summary
- As of March 9, 2025, FDMT quarterly total liabilities is $49.78 million, with the most recent change of -$1.30 million (-2.55%) on December 1, 2024.
- Over the past year, FDMT quarterly total liabilities has increased by +$18.00 million (+56.65%).
- FDMT quarterly total liabilities is now -62.06% below its all-time high of $131.20 million, reached on December 31, 2019.
Performance
FDMT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
FDMT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.3% | +56.6% |
| 3 y3 years | +44.8% | +57.1% |
| 5 y5 years | -62.1% | +57.1% |
FDMT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.2% | -2.5% | +95.9% |
| 5 y | 5-year | -62.1% | +63.2% | -62.1% | +248.4% |
| alltime | all time | -62.1% | +63.2% | -62.1% | +248.4% |
4D Molecular Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $49.78 M(+55.3%) | - |
| Dec 2024 | - | $49.78 M(-2.5%) |
| Sep 2024 | - | $51.08 M(+60.7%) |
| Jun 2024 | - | $31.78 M(+8.4%) |
| Mar 2024 | - | $29.32 M(-8.5%) |
| Dec 2023 | $32.06 M(+5.1%) | $32.06 M(+1.2%) |
| Sep 2023 | - | $31.68 M(+15.8%) |
| Jun 2023 | - | $27.36 M(+7.6%) |
| Mar 2023 | - | $25.41 M(-16.7%) |
| Dec 2022 | $30.51 M | $30.51 M(+6.2%) |
| Sep 2022 | - | $28.72 M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $30.42 M(+5.4%) |
| Mar 2022 | - | $28.87 M(-16.0%) |
| Dec 2021 | $34.38 M(+7.6%) | $34.38 M(+108.6%) |
| Sep 2021 | - | $16.48 M(+15.4%) |
| Jun 2021 | - | $14.29 M(-48.4%) |
| Mar 2021 | - | $27.68 M(-13.3%) |
| Dec 2020 | $31.94 M(-75.7%) | $31.94 M(+13.9%) |
| Sep 2020 | - | $28.04 M(-78.6%) |
| Dec 2019 | $131.20 M(+5.3%) | $131.20 M(+6.8%) |
| Jun 2019 | - | $122.80 M(-1.4%) |
| Dec 2018 | $124.56 M(+165.5%) | $124.56 M |
| Dec 2017 | $46.91 M | - |
FAQ
- What is 4D Molecular Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual total liabilities year-on-year change?
- What is 4D Molecular Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly total liabilities year-on-year change?
What is 4D Molecular Therapeutics annual total liabilities?
The current annual total liabilities of FDMT is $49.78 M
What is the all time high annual total liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual total liabilities is $131.20 M
What is 4D Molecular Therapeutics annual total liabilities year-on-year change?
Over the past year, FDMT annual total liabilities has changed by +$17.72 M (+55.26%)
What is 4D Molecular Therapeutics quarterly total liabilities?
The current quarterly total liabilities of FDMT is $49.78 M
What is the all time high quarterly total liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly total liabilities is $131.20 M
What is 4D Molecular Therapeutics quarterly total liabilities year-on-year change?
Over the past year, FDMT quarterly total liabilities has changed by +$18.00 M (+56.65%)